Takeda Pharmaceutical
TAK
#341
Rank
$46.62 B
Marketcap
$14.66
Share price
-1.97%
Change (1 day)
5.51%
Change (1 year)

Operating Margin for Takeda Pharmaceutical (TAK)

Operating Margin as of October 2023 (TTM): 14.33%

According to Takeda Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 14.33%. At the end of 2023 the company had an Operating Margin of 9.31%.

Operating Margin history for Takeda Pharmaceutical from 2009 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
20239.31%9.86%
20228.48%-25.98%
202111.45%-720.42%
2020-1.85%-140.8%
20194.52%-63.12%
201812.27%48.23%
20178.28%24.09%
20166.67%-181.53%
2015-8.18%-187.12%
20149.39%12.74%
20138.33%-50.22%
201216.73%-36.08%
201126.18%-7.71%
201028.37%9.49%
200925.91%-38.25%
200841.96%-12.43%
200747.92%12.14%
200642.73%8.78%
200539.28%-4.35%
200441.07%-0.54%
200341.29%11.12%
200237.15%36.07%
200127.30%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
22.88% 59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
17.27% 20.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
34.61% 141.52%๐Ÿ‡บ๐Ÿ‡ธ USA
34.59% 141.38%๐Ÿ‡บ๐Ÿ‡ธ USA
18.21% 27.08%๐Ÿ‡ซ๐Ÿ‡ท France
27.73% 93.51%๐Ÿ‡บ๐Ÿ‡ธ USA
22.54% 57.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
-30.69%-314.17%๐Ÿ‡บ๐Ÿ‡ธ USA
24.69% 72.30%๐Ÿ‡ฎ๐Ÿ‡ณ India

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.